Contact us contattaci
logo
logo

Gallarate

Home / Manufacturing sites / Gallarate

Manufacturing site

The Biofarma site in Gallarate has special expertise in the development, production and packaging of nutraceuticals in solid forms, medical devices for oral use and sports nutrition products. The plant boats a strong expertise in the design and production of multi-layer tablets and advance coating solutions for healthcare industry.

The Gallarate site manufactures solid forms, packaged in blisters and bottles, and offers quality services such as analytical & microbiological testing; stability studies, development and testing of packaging components, as galenical & analytical development. The site offers its partners a full service: procurement, production, analytics, stability, project management, release, customer service.

Facility facts

The figures of Biofarma Group's Gallarate plant Distinctive technologies

Gallarate facility delivers rapid and flexible solutions for the development and production of different major solid dosage forms. With a focus on innovation and quality, the plant specializes in a wide variety of galenic formulations, expertly tailored to meet the diverse needs of our customers:

  1. Multi-layer tablets

  2. ODT (orally disintegrating tablets)

  3. Chewable tablets

  4. Microencapsulation

Multi-layer tablets

Multi-layer tablet is an innovative technology for the oral administration of advanced formulations, incorporating active ingredients or mixtures of active substances with controlled and sustained release in a single product. Thanks to this technology, the product's action is optimised over time, ensuring a more targeted and effective action in the body. A guarantee in health care, for long-lasting, high-performance results.

Three-layer tablets manufactured in Biofarma Group's Gallarate plant

The Advantages:

  1. Prevention of incompatibility between active ingredients and excipients, which are kept separate from each other until the time of administration

  2. Administration of the same or different substances, with controlled release and with a direct and diversified action in the target area

  3. The use of separate layers and different colours differentiates the product from other tablets and provides visual evidence of the use of different groups of ingredients (e.g. vitamins and minerals)

Microencapsulation

Microencapsulation is the protective technology of encapsulating solid and liquid materials into microparticles with a diameter of 1 1000 μm and has been widely used in fields of medicine, cosmetics, food supplements textile and advanced materials: Gallarate plant boats a strong expertise in using this innovative technology, which is suitable for powders, capsules and tablets, to coat and protect an ingredient while keeping it active and stabilized.

Microencapsulation machine, a process carried out in Biofarma Group's Gallarate plant

The main benefits of microencapsulation:

  1. Controlled release in the body and during processing

  2. Flavor and odor masking

  3. Protection of nutrients for increased stability

  4. Ease of handling in production

  5. Increased effectiveness

Highlights

Certifications

ISO 13485 (Medical Devices); ISO 9001; GMP CRF TITLE 21, VOL 2, PART 111 (Supplements); PET FOOD SUPPLEMENT AUTHORIZATION (ART 10 OF REG. 183/2005/CE); FOOD SAFETY SYSTEM CERTIFICATION FSSC 22000; KOSHER; HALAL; BIOLOGIC; FDA REGISTRATION

Production capabilities

Food supplements liquids; medical devices; probiotics

Contacts

Via Gran Bretagna, 1 - 21013 Gallarate (VA) – Italia

Tel.: +39 0331 1831038

E-mail: marketing@biofarmagroup.it

Want to learn more? Contact us

Captcha non valido!

loading
Contacts image
logo
© Biofarma Srl C.F. and P.IVA 02895910301
T. +39 0432 868711 F. +39 0432 868018
Via Castelliere, 2
33036 Mereto di Tomba (UD) Italy
Number REA UD - 296214
Date of entry in the
Business Register of UDINE: 01/07/2017
Registration number: 02895910301
Share capital euro 3.000.000